Generative AI systems operate differently enough that some assumptions underpinning today's governance approaches warrant ...

Forbes contributors publish independent expert analyses and insights. Gary Drenik is a writer covering AI, analytics and innovation. AI rarely fails because of bad models alone. More often it fails ...

Lineage (LINE) stands out as the cold storage industry leader, leveraging proprietary technology and geographic diversification to drive structural cost advantages over peers. LINE’s LinOS platform is ...

Multiple analysts initiated Buy ratings on Lineage, citing its strong acquisition track record and technological investments. Analysts project high single-digit growth in AFFO and EBITDA for Lineage ...

CARLSBAD, Calif.--(BUSINESS WIRE)--Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing allogeneic cell therapies for unmet medical needs, ...

Lineage (LINE), the world’s largest cold storage operator, is trading over 50% below recent highs but remains a dominant industry force. LINE is well-positioned for long-term growth and industry ...

As your data evolves, you need a way to track the who, what, when, why, and how of those changes. You need a data lineage system. Databases are good at inserting, updating, querying, and deleting data ...

Lineage expects steady 2026 after challenging 2025 as Q4 revenue was little changed and the CEO cited early signs of stabilization. The company saw 4.4% warehousing revenue growth but slight occupancy ...

PANGYO, South Korea--(BUSINESS WIRE)--NCSOFT (KRX:036570), a global premier game developer and publisher, revealed the company’s new mobile MMORPG ‘Lineage W’ through a global online showcase titled ...

Ratings for Lineage Cell Therapeutics (AMEX:LCTX) were provided by 4 analysts in the past three months, showcasing a mix of bullish and bearish perspectives. The table below summarizes their recent ...